一名军事服务人员的耐火性骨髓炎通过辅助高压氧气疗法解决
Jeffrey Spiro1, Michael Gedestad2, Piotr Wisniewski3,4
1Division of Infectious Diseases, Naval Medical Center San Diego, San Diego, CA 92134, USA.
Military medicine
|January 9, 2024
概括
耐火性骨髓炎是一种持续的骨感染,治疗可能具有挑战性. 辅助高压氧疗法 (HBOT) 在解决复杂病例方面被证明是有效的,这表明它在类似情况下的潜在实用性.
科学领域:
- 整形外科 整形外科 整形外科
- 传染性疾病 传染性疾病
- 高压医学高压医学
背景情况:
- 耐火性骨髓炎是一种慢性骨感染,尽管经过手术和服用抗生素,但仍然存在.
- 复杂的病例,如开放性骨折,需要长时间的治疗和多次干预.
- 对于具有挑战性的骨髓炎病例,需要新的治疗辅助.
研究的目的:
- 报告一例耐火性骨髓炎的病例,该病例已通过辅助高压氧疗法 (HBOT) 成功治疗.
- 突出HBOT作为复杂骨感染的未充分利用资源的潜力.
主要方法:
- 一名47岁的军人接受了治疗,他患有开脚骨折的耐火性骨髓炎.
- 患者经历了9个月的多次失败的医疗和外科管理课程.
- 进行了辅助高压氧疗法 (HBOT).
主要成果:
- 辅助高压氧疗法 (HBOT) 导致耐火性骨髓炎的解决.
- 在传统方法失败后,这种治疗方法取得了成功.
结论:
- 辅助高压氧疗法 (HBOT) 可以成为选择性骨质炎患者的安全和有效治疗方法.
- 需要进一步的研究来探索HBOT的作用,特别是在军事人口中.
- 增加可用性和高质量的数据可以促进对复杂感染的HBOT的更广泛采用.
相关概念视频
Flail Chest-II
174
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
174
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
216
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
216
Pneumothorax-II
153
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
153
Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
Acute Respiratory Failure-V
141
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
141
Acute Respiratory Failure-III
187
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187


